A Case of Systemic Anaplastic Large Cell Lymphoma with Secondary Cutaneous Involvement

Main Article Content

Andie Bulbin
Sarah Stano
Kalliope Kyriakides
Paul Chu
Cindy Hoffman

Keywords

cutaneous lymphoma, ALCL, ALK-negative ALCL, sALCL

Abstract

Systemic anaplastic large cell lymphoma (sALCL) is a rare, malignant T-cell lymphoma characterized by CD30 expression. There are two subtypes: ALK-positive sALCL and ALK-negative sALCL. In either condition, extranodal involvement is uncommon. We report a unique case in a 75-year-old woman who presented with multiple crops of occasionally pruritic papules in different stages of healing along her back for 3-4 weeks. The patient also showed erythematous papules on her arms, as well as lymphadenopathy. After considering other cutaneous T-cell lymphomas, the ultimate diagnosis of ALK-negative sALCL was determined using the clinical data, results of punch biopsy, and immunohistochemical staining.  

References

1. Pina-Oviedo S, Ortiz-Hidalgo C, Carballo-Zarate AA, Zarate-Osorno A. Alk-negative anaplastic large cell lymphoma: Current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas. Cancers. 2021;13(18):4667. doi:10.3390/cancers13184667

2. Swerdlow SH, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, et al. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer (IARC); Lyon, France: 2017.

3. Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017;8(11):18525-18536. doi:10.18632/oncotarget.14503

4. Siegel L, Sirota-Rosenberg S. Primary Systemic Anaplastic Large-Cell Lymphoma: A Case Report. Journal of the American Osteopathic College of Dermatology. 2018;39.

5. Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M. Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges. 2016;14(8):767-782. doi:10.1111/ddg.13117